Does Rhode Island Medicaid or the state employee plan cover GLP-1s for weight loss in 2026?
No, as of October 1, 2026. Rhode Island Medicaid no longer covers Foundayo, Saxenda, Wegovy and Zepbound when prescribed solely for weight loss, per a Rhode Island EOHHS memo (August 2026). Other medically necessary uses need a new prior authorization. We couldn't confirm the current state employee plan rule. Check your plan documents or your state benefits office for your renewal date.
Compounded drugs are not FDA-approved. Education only, not medical advice. Coverage rules change; confirm with your plan or state Medicaid office. NuvoTrim is not affiliated with any government agency, Medicaid program or state employee plan.
Frequently asked questions
Does Rhode Island Medicaid cover GLP-1s for weight loss?
No, as of October 1, 2026. Rhode Island Medicaid no longer covers Foundayo, Saxenda, Wegovy and Zepbound when prescribed solely for weight loss, per a Rhode Island EOHHS memo (August 2026). Other medically necessary uses need a new prior authorization.
Does the Rhode Island state employee plan cover GLP-1s for weight loss?
We couldn't confirm the current state employee plan rule. Check your plan documents or your state benefits office for your renewal date.
Does Medicaid still cover GLP-1s for diabetes?
Yes. Per KFF, Medicaid must cover GLP-1s approved for type 2 diabetes; weight-loss coverage is optional for each state.
How do compounded GLP-1s compare with Wegovy or Zepbound?
They are not the same products. Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness or quality.